Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte C Widemann

Showing results (31-40 of 203) with videos related to

Pageof 21
Sort By:
Journal of Pediatric Hematology/Oncology|August 7, 2003
Evaluation and treatment of fever in the non-neutropenic child with cancerWanda Salzer, Seth M Steinberg, David J Liewehr, et al.
Sarcoma|June 9, 2017
Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective TherapiesAeRang Kim, Douglas R Stewart, Karlyne M Reilly, et al.
Journal of Family Psychology : JFP : Journal of the Division of Family Psychology of the American Psychological Association (Division 43)|October 17, 2024
Parent-child discrepancies in reports of child psychosocial functioning in neurofibromatosis type 1Nour Al Ghriwati, Paige Little, Staci Martin, et al.
Pediatric Blood & Cancer|July 25, 2015
Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology GroupAeRang Kim, Brigitte C Widemann, Mark Krailo, et al.
Journal of Neuro-Oncology|June 10, 2025
Whole Body-MRI assessment of peripheral lesions in patients with NF2-related schwannomatosis on systemic bevacizumabShivani Ahlawat, Patrick Debs, Laura M Fayad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2025
Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform NeurofibromasEva Dombi, Andrea M Gross, Brigitte C Widemann, et al.
The Oncologist|July 6, 2022
Reporting of Racial and Ethnic Minority Representation in Early Phase Pediatric Oncology Clinical TrialsAiman J Faruqi, John A Ligon, Julia W Cohen, et al.
Frontiers in Oncology|December 3, 2014
Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumorsJenna Kahn, Andy Gillespie, Maria Tsokos, et al.
Investigational New Drugs|November 13, 2010
The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primatesAeRang Kim, Cindy McCully, Rafael Cruz, et al.
Future Oncology (London, England)|June 13, 2024
Selumetinib for children with neurofibromatosis type 1 and plexiform neurofibromas: A plain language summary of SPRINTAndrea M Gross, Colette Achée, Sarah E Hart, et al.
Pageof 21

Showing results (31-40 of 203) with videos related to

Sort By:
Pageof 21
Journal of Pediatric Hematology/Oncology|August 7, 2003
Evaluation and treatment of fever in the non-neutropenic child with cancerWanda Salzer, Seth M Steinberg, David J Liewehr, et al.
Sarcoma|June 9, 2017
Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective TherapiesAeRang Kim, Douglas R Stewart, Karlyne M Reilly, et al.
Journal of Family Psychology : JFP : Journal of the Division of Family Psychology of the American Psychological Association (Division 43)|October 17, 2024
Parent-child discrepancies in reports of child psychosocial functioning in neurofibromatosis type 1Nour Al Ghriwati, Paige Little, Staci Martin, et al.
Pediatric Blood & Cancer|July 25, 2015
Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology GroupAeRang Kim, Brigitte C Widemann, Mark Krailo, et al.
Journal of Neuro-Oncology|June 10, 2025
Whole Body-MRI assessment of peripheral lesions in patients with NF2-related schwannomatosis on systemic bevacizumabShivani Ahlawat, Patrick Debs, Laura M Fayad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2025
Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform NeurofibromasEva Dombi, Andrea M Gross, Brigitte C Widemann, et al.
The Oncologist|July 6, 2022
Reporting of Racial and Ethnic Minority Representation in Early Phase Pediatric Oncology Clinical TrialsAiman J Faruqi, John A Ligon, Julia W Cohen, et al.
Frontiers in Oncology|December 3, 2014
Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumorsJenna Kahn, Andy Gillespie, Maria Tsokos, et al.
Investigational New Drugs|November 13, 2010
The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primatesAeRang Kim, Cindy McCully, Rafael Cruz, et al.
Future Oncology (London, England)|June 13, 2024
Selumetinib for children with neurofibromatosis type 1 and plexiform neurofibromas: A plain language summary of SPRINTAndrea M Gross, Colette Achée, Sarah E Hart, et al.
Pageof 21